Febuxostat Tablet
Product Images NDC 59651-113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 59651-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label.principal Display Panel (40 mg (30 Tablets Bottle))

Package Label.principal Display Panel (40 mg (30 Tablets Bottle))
Each film-coated tablet contains 40 mg of febuxostat. It is distributed by Aurobindo Pharma USA, Inc. and manufactured in India. The usual dosage should be followed as mentioned in the package insert. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F), protected from light. It should be dispensed by a pharmacist and a medication guide will be provided to each patient separately. This product is only available with a prescription and comes in a bottle containing 30 tablets. The National Drug Code (NDC) for this product is 59651-113-30. Ensure the seal over the bottle opening is intact and unbroken, do not accept if it is broken or missing. The text also contains irrelevant and unreadable characters.*
FDA Label Image

Package Label.principal Display Panel (80 mg (30 Tablets Bottle))

Package Label.principal Display Panel (80 mg (30 Tablets Bottle))
FDA Label Image

Chemical Structure (Febuxostat Str)

Chemical Structure (Febuxostat Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.